Ekso Bionics Holdings, Inc. (OTCBB:EKSO)’s Ascent Comes To A Halt

[[tagnumber 0]][[tagnumber 1]]The overall performance of Ekso Bionics Holdings, Inc. (OTCBB:EKSO) in the past month has been positive and, despite the many sessions that ended in the red the ticker has somehow managed to climb higher in the charts.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]That’s due to the high gains the company has managed to make on positive press releases that announced a National Institute of Health grant for the development of a pediatric rehabilitation exoskeleton, a collaboration with [[tagnumber 6]]Ottobock [[tagnumber 7]]and [[tagnumber 6]]EKSO’s [[tagnumber 7]]involvement in the Warrior Web [[tagnumber 6]]DARPA [[tagnumber 7]]project alongside Boston Dynamics, a company that was acquired by Google, Inc. (NASDAQ:GOOG) in the end of last year.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]More recently, [[tagnumber 6]]EKSO [[tagnumber 7]]received a boost after the company announced that it will be holding a conference call this Tuesday. While the market didn’t react in the day of the announcement, [[tagnumber 6]]EKSO [[tagnumber 7]]did make a good 18.62% jump in the following session on a significant $3.25 million dollar volume.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The run continued in the first session for this week as [[tagnumber 6]]EKSO [[tagnumber 7]]added another 7.56% with an even higher daily trade value of $5.18 million, but Tuesday ended in the red and the ticker closed 6.49% down. Still, the latest quarterly report that was filed yesterday did manage to bring another positive session for [[tagnumber 6]]EKSO[[tagnumber 7]].[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Here is what the numbers of prime interest contained in the balance sheet for the period ended September 30 looked like.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 35]] [[tagnumber 36]]cash: $7.17 million[[tagnumber 37]] [[tagnumber 36]]current assets: $11.66 million[[tagnumber 37]] [[tagnumber 36]]total assets: $15.41 million[[tagnumber 37]] [[tagnumber 36]]current liabilities: $5.89 million[[tagnumber 37]] [[tagnumber 36]]total liabilities: $21.34 million[[tagnumber 37]] [[tagnumber 36]]quarterly revenues: $1.58 million[[tagnumber 37]] [[tagnumber 36]]loss from operations: $3.73 million[[tagnumber 37]] [[tagnumber 50]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Overall, [[tagnumber 6]]EKSO [[tagnumber 7]]is one of the more stable companies in the OTC markets, but despite the fact that their business is expanding it still has a long way until it becomes profitable. After yesterday’s 5.20% gain the ticker was sitting at $1.82 per share, while the market cap totaled $143 million.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Surely, there is a great potential in pioneers such as [[tagnumber 6]]EKSO[[tagnumber 7]], but that still doesn’t mean you should skip your due diligence and weigh out the risks before making any investments.[[tagnumber 2]]